Kidney transplant options for the diabetic patient.
For patients with diabetes and progressive chronic kidney disease, kidney transplantation is the optimal mode of renal replacement therapy, with or without a pancreas transplant. Additional benefits of pancreas transplant have become increasingly apparent due to advances in surgical outcomes and immunosuppression, and may be reasonably considered even in selected patients with type 2 diabetes. In general, pancreas transplantation is associated with long-term survival advantages despite an increased short-term morbidity and mortality risk. This is true with simultaneous pancreas kidney transplantation or pancreas after kidney transplantation compared to kidney transplantation alone, regardless of kidney donor status (living or deceased). Individual patient preferences, comorbidities, and expected waiting time influence selection of transplant modality, rather than a clear survival benefit of one strategy versus the other. In selected patients with type 2 diabetes, recent outcomes data support cautious utilization of simultaneous pancreas kidney transplantation when a living kidney donor transplant is not an option. The purpose of this review is to summarize current data regarding kidney and pancreas transplant treatment options in patients with both type 1 and 2 diabetes and the influence of current organ allocation policies to better understand the advantages and disadvantages of each of these strategies.
Transplant Center, University of Colorado Denver, Mail Stop F749, AOP 7089, 1635 North Aurora Court, Aurora, CO 80045. Electronic address: Alexander.wiseman@ucdenver.edu.
Alexander C
AC
Wiseman
D048909:Diabetes Complications / Q000150:complications / Q000401:mortality / Q000601:surgery*; D014943:Global Health; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000379:methods*; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000401:mortality / Q000601:surgery*; D015996:Survival Rate / Q000639:trends